Seller record · goodgirlrx.com

GoodGirlRx

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The terms, the product pages and the ownership answer refer only to independent, state-licensed partner pharmacies. 1 more criterion also fails; see the table below.

At a glance

GoodGirlRxgoodgirlrx.com

6/8criteria passed

Price: Semaglutide $179, tirzepatide $329 a month
Sells: compounded semaglutide injection, microdose and tablets, and 9 more
FDA letters: 1 on file

Unpaid link. GoodGirlRx does not pay the site. Funding

Visit GoodGirlRx See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service for women selling compounded semaglutide and tirzepatide as injections, microdoses and tablets, with sermorelin, NAD+, glutathione and PT-141, and brand GLP-1 drugs at list price. An FDA warning letter of February 2026 cited its pictured labels and its FDA-approved claims, and it names no filling pharmacy.

Operating entity Good Girl, LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	goodgirlrx.com/terms
S2	Prescription gating	PASS	care.goodgirlrx.com/start-online-visit/weight-loss, goodgirlrx.com/find-my-treatment
S3	Pharmacy identification	FAIL	goodgirlrx.com/terms, goodgirlrx.com/who-owns-good-girl-rx
S4	Compounding disclosure	PASS	goodgirlrx.com/products/semaglutide
S5	Analytical documentation	FAIL	goodgirlrx.com/products, goodgirlrx.com/safety
S6	Business address	PASS	goodgirlrx.com/contact, goodgirlrx.com/who-owns-good-girl-rx
S7	Price disclosure	PASS	goodgirlrx.com/products/semaglutide, goodgirlrx.com/products/tirzepatide, goodgirlrx.com/products/nad-plus
S8	Enforcement status	PASS	fda.gov, letter 721449

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSPrescriptions come from board-certified physicians licensed in the patient's state through Beluga Health, P.A., and the terms state that Good Girl LLC provides the technology platform and no medical services.Source: goodgirlrx.com/terms.

S2PASSEvery start button opens an online visit that begins with a health assessment, the treatment finder opens by asking the primary health goal, and no cart exists.Source: care.goodgirlrx.com/start-online-visit/weight-loss, goodgirlrx.com/find-my-treatment.

S3FAILNo filling pharmacy is named. The terms, the product pages and the ownership answer refer only to independent, state-licensed partner pharmacies.Source: goodgirlrx.com/terms, goodgirlrx.com/who-owns-good-girl-rx.

S4PASSCompounded semaglutide is prepared by state-licensed compounding pharmacies and has not been reviewed by the FDA for safety, effectiveness, or quality, printed on each compounded product page.Source: goodgirlrx.com/products/semaglutide.

S5FAILNo certificate of analysis or lot report appears on any product page, the safety pages or the policies.Source: goodgirlrx.com/products, goodgirlrx.com/safety.

S6PASSGood Girl, LLC at 1005 17th Avenue South, Suite 900, Nashville, TN 37212, printed on the contact page and in the ownership answer.Source: goodgirlrx.com/contact, goodgirlrx.com/who-owns-good-girl-rx.

S7PASSCompounded semaglutide at $179 a month month to month or $134 a month on a prepaid twelve-month plan, tirzepatide at $329 or $235 a month on the same terms, and NAD+ at $249 a month or $183 a month on a prepaid quarter.Source: goodgirlrx.com/products/semaglutide, goodgirlrx.com/products/tirzepatide, goodgirlrx.com/products/nad-plus.

S8PASSFDA warning letter 721449, February 2026, names Good Girl LLC dba GoodGirlRX at 1005 17th Avenue South, Nashville, alleging that pictured labels presented GoodGirlRX as the compounder of its semaglutide and tirzepatide and that claims such as FDA-approved meds were false or misleading. No FDA action has halted the business, and the storefront still trades.Source: fda.gov, letter 721449.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection, microdose and tablets, compounded tirzepatide injection, microdose and tablets, brand Ozempic, Wegovy, Zepbound and Mounjaro, Wegovy pill, NAD+ injection, nasal spray and face cream, sermorelin injection and tablets, glutathione, PT-141, B12 and lipotropic injections, estradiol and progesterone.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione Who sells PT-141

Enforcement documents on file: 1 warning letter

FDA warning letter 721449, issued February 2026, to Good Girl LLC dba GoodGirlRXPictured labels identify GoodGirlRX as the compounder of semaglutide and tirzepatide products when it is not, and claims such as FDA-approved meds represent compounded products as FDA-approved when they are not.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Unpaid link. GoodGirlRx does not pay the site, and nothing is earned when it is used. Funding.

Visit GoodGirlRx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.